Invesco Ltd. lessened its holdings in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 42.0% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,534,381 shares of the health services provider's stock after selling 1,109,562 shares during the quarter. Invesco Ltd. owned 1.19% of Select Medical worth $25,624,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. GAMMA Investing LLC lifted its position in Select Medical by 217.4% during the first quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock worth $109,000 after purchasing an additional 4,453 shares during the period. Lazard Asset Management LLC lifted its position in Select Medical by 47.8% during the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock worth $130,000 after purchasing an additional 2,255 shares during the period. Wealthquest Corp bought a new stake in Select Medical during the first quarter worth about $143,000. Quarry LP lifted its position in Select Medical by 963.0% during the fourth quarter. Quarry LP now owns 9,078 shares of the health services provider's stock worth $171,000 after purchasing an additional 8,224 shares during the period. Finally, HBK Investments L P bought a new stake in Select Medical during the fourth quarter worth about $188,000. Institutional investors own 89.48% of the company's stock.
Select Medical Stock Up 0.2%
Shares of NYSE SEM opened at $12.9160 on Thursday. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.92. The company has a market cap of $1.60 billion, a price-to-earnings ratio of 12.19, a PEG ratio of 0.68 and a beta of 1.25. Select Medical Holdings Corporation has a 12 month low of $11.65 and a 12 month high of $40.98. The stock has a 50-day moving average price of $14.12 and a two-hundred day moving average price of $15.83.
Select Medical (NYSE:SEM - Get Free Report) last issued its earnings results on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, topping the consensus estimate of $0.28 by $0.04. The firm had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.35 billion. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The business's quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.60 earnings per share. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. As a group, analysts forecast that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.
Select Medical declared that its board has initiated a stock buyback plan on Thursday, May 1st that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to buy up to 42.6% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's board of directors believes its stock is undervalued.
Select Medical Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th will be paid a $0.0625 dividend. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $0.25 annualized dividend and a dividend yield of 1.9%. Select Medical's dividend payout ratio is currently 23.58%.
Analysts Set New Price Targets
SEM has been the subject of several recent analyst reports. Royal Bank Of Canada cut their price objective on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research report on Wednesday, May 7th. UBS Group reaffirmed a "neutral" rating and set a $14.00 price objective (down previously from $15.00) on shares of Select Medical in a research report on Monday, August 4th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $20.25.
Get Our Latest Stock Report on Select Medical
About Select Medical
(
Free Report)
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Articles
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Corporation (NYSE:SEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Select Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.
While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.